ACTIVE

TESCAN XRE

Financial year 2025 · Closed on 31/12/2025

Net result191,1 k €+17,2 %over 1 year
Gross margin2,4 M €+27,0 %over 1 year
Equity961 k €+24,8 %over 1 year
Workforce14,8 ETP+25,4 %over 1 year

Identity

Source · BCE/KBO

TESCAN XRE is a Public limited company incorporated in 2011. Its main activity is: Engineering activities and related technical consultancy. Its registered office is in Gent. It employs on average 14,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0839.520.152
Incorporation
21/09/2011
Legal form
Public limited company
Registered office
Bollebergen 2B box 1
9052 Gent · FlandreSee on map
Contributed capital
267 200,00 €
Latest accounts
31/12/2025
Average workforce
14,8 ETP
Joint committees (2)
  • 200
  • 20000
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 14 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin2,4 M €1,9 M €1,4 M €1,8 M €1,3 M €
EBITDA543,3 k €445,7 k €329,7 k €759,1 k €418,6 k €
Operating result227,9 k €222,4 k €207,7 k €659,4 k €246,2 k €
Net result191,1 k €163,1 k €153,2 k €541,2 k €224,3 k €
Balance sheet
Equity961 k €769,9 k €606,9 k €453,7 k €-87,6 k €
Total assets2,6 M €2,3 M €2,1 M €2 M €2,9 M €
Cash220,4 k €967,4 k €340,1 k €243,4 k €61 k €
Debts1,3 M €1,5 M €1,4 M €1,4 M €2,9 M €
Other
Workforce14,8 ETP11,8 ETP10,1 ETP11,6 ETP9,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 20 ended

Active mandates

AQUOS

Managing director · since 15 mars 2025 · until 15 mars 2031 · 0891.452.566

Represented by JANSSENS BRUNO

Active
JEAN-CHARLES CHEN

Director · since 01 juin 2023 · until 18 mai 2029

Active
PAVEL SUSTEK

Director · since 01 juin 2023 · until 18 mai 2029

Active

Ended mandates

BJORN DE SMET

Managing director · since 01 juin 2023 · until 18 mai 2029

Ended
KOSTAL VRATISLAV

Director · since 30 mai 2022 · until 18 mars 2024

Ended
Anne Delobbe

Director · since 19 août 2018 · until 18 mars 2024

Ended
L3 MANAGEMENT

Managing director · since 22 mars 2018 · until 18 mars 2024 · 0849.587.267

Represented by Jelle Vlassenbroeck

Ended

Other companies at this address

Bollebergen 2B 9052 Gent
CompanyCBE no.
0776.661.380
Indigo Diabetes● Active
0666.442.557
0459.285.397
0685.982.119

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date10/06/202614/06/202512/06/202412/06/202316/06/202221/06/2021
General meeting15/05/202616/05/202517/05/202419/05/202320/05/202221/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202515/05/202610/06/2026DutchPDF
Abridged model31/12/202416/05/202514/06/2025DutchPDF
Abridged model31/12/202317/05/202412/06/2024DutchPDF
Abridged model31/12/202219/05/202312/06/2023DutchPDF
Abridged model31/12/202120/05/202216/06/2022DutchPDF
Abridged model31/12/202021/05/202121/06/2021DutchPDF
Abridged model31/12/201931/03/202029/04/2020DutchPDF
Abridged model31/12/201829/03/201929/04/2019DutchPDF
Micro model31/12/201716/03/201813/04/2018DutchPDF
Micro model31/12/201631/03/201727/04/2017DutchPDF
Abridged model31/12/201531/03/201631/08/2016DutchPDF
Abridged model31/12/201430/06/201531/08/2015DutchPDF
Abridged model31/12/201331/03/201418/07/2014DutchPDF
Abridged model31/12/201229/03/201320/08/2013DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 20 ended

Active mandates

AQUOS

Managing director · since 15 mars 2025 · until 15 mars 2031 · 0891.452.566

Represented by JANSSENS BRUNO

Active
JEAN-CHARLES CHEN

Director · since 01 juin 2023 · until 18 mai 2029

Active
PAVEL SUSTEK

Director · since 01 juin 2023 · until 18 mai 2029

Active

Ended mandates

BJORN DE SMET

Managing director · since 01 juin 2023 · until 18 mai 2029

Ended
KOSTAL VRATISLAV

Director · since 30 mai 2022 · until 18 mars 2024

Ended
Anne Delobbe

Director · since 19 août 2018 · until 18 mars 2024

Ended
L3 MANAGEMENT

Managing director · since 22 mars 2018 · until 18 mars 2024 · 0849.587.267

Represented by Jelle Vlassenbroeck

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/08/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/12/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other04/01/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ALGEMENE VERGADERING
    PDF
  • Other06/03/2019
    BENAMING
    PDF
  • Mandates17/05/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/04/2018
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025191,1 k €↑
  2. 2024
    Annual accounts 2024163,1 k €↑
  3. 2023
    Annual accounts 2023153,2 k €↓
  4. 2023
    Name changeTESCAN XRE
  5. 2022
    Annual accounts 2022541,2 k €↑
  6. 2021
    Annual accounts 2021224,3 k €↑
  7. 2021
    Name changeXRE
  8. 2020
    Annual accounts 2020240 €↑
  9. 2019
    Annual accounts 2019-451,7 k €↓
  10. 2018
    Annual accounts 2018-337,3 k €↓
  11. 2016
    Annual accounts 201657,2 k €↓
  12. 2015
    Annual accounts 201561,4 k €↑
  13. 2014
    Annual accounts 201444,8 k €↑
  14. 2013
    Annual accounts 201318,2 k €↑
  15. 2012
    Annual accounts 201216,9 k €
  16. 21/09/2011
    IncorporationPublic limited company